10-K Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001558370-23-002419`
Period End Date	20221231
Filing Date	20230228
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	iova-20221231x10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 61 Income Statement 30 Cash Flow Statement 84 Stockholders Equity 28 Comprehensive Income 9

Balance Sheet 61 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$231.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$67.33M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$78.23M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$240.11M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$426.18M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.55M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$7.27M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$479.12M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$507.96M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$100.94M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$105.23M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$73.02M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$68.98M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	157.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	187.81M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$91.59M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	157.00M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	187.81M	shares	Point-in-time
Restricted cash	`RestrictedCash`	$6.43M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$6.08M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$5.53M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$1.78M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$189.00K	USD	Point-in-time
Total Assets	`Assets`	$777.33M	USD	Point-in-time
Total Assets	`Assets`	$663.98M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$27.38M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$26.60M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$52.30M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$56.77M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$12.59M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$5.06M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$91.48M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$89.20M	USD	Point-in-time
Operating lease liabilities - non-current	`OperatingLeaseLiabilityNoncurrent`	$65.47M	USD	Point-in-time
Operating lease liabilities - non-current	`OperatingLeaseLiabilityNoncurrent`	$71.86M	USD	Point-in-time
Long-term note payable	`LongTermNotesPayable`	$1.00M	USD	Point-in-time
Long-term note payable	`LongTermNotesPayable`	$1.00M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$72.86M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$66.47M	USD	Point-in-time
Total Liabilities	`Liabilities`	$164.34M	USD	Point-in-time
Total Liabilities	`Liabilities`	$155.67M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 187,812,072 and 157,004,742 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 187,812,072 and 157,004,742 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-902.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-601.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.07B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.79B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.17B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.57B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$298.97M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$499.64M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$621.66M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$656.50M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$777.33M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$663.98M	USD	Point-in-time

Income Statement 30 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$259.04M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$201.73M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$294.78M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$83.66M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$60.21M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$104.10M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$342.70M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$398.88M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$261.94M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-261.94M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-398.88M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-342.70M	USD	Annual
Interest income, net	`InvestmentIncomeInterest`	$2.36M	USD	Annual
Interest income, net	`InvestmentIncomeInterest`	$2.98M	USD	Annual
Interest income, net	`InvestmentIncomeInterest`	$451.00K	USD	Annual
Net Loss	`NetIncomeLoss`	$-259.58M	USD	Annual
Net Loss	`NetIncomeLoss`	$-342.25M	USD	Annual
Net Loss	`NetIncomeLoss`	$-395.89M	USD	Annual
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-1.88	USD	Annual
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-2.23	USD	Annual
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-2.49	USD	Annual
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-2.49	USD	Annual
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-1.88	USD	Annual
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-2.23	USD	Annual
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	138,301.00	shares	Annual
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	159,259.00	shares	Annual
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	153,406.00	shares	Annual
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	159,259.00	shares	Annual
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	138,301.00	shares	Annual
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	153,406.00	shares	Annual

Cash Flow Statement 84 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-259.58M	USD	Annual
Net loss	`NetIncomeLoss`	$-342.25M	USD	Annual
Net loss	`NetIncomeLoss`	$-395.89M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$69.77M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$40.89M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$84.02M	USD	Annual
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$10.87M	USD	Annual
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$11.82M	USD	Annual
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$7.57M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.11M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.14M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$9.31M	USD	Annual
Accretion of discounts and premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-6.01M	USD	Annual
Accretion of discounts and premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.86M	USD	Annual
Accretion of discounts and premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-474.00K	USD	Annual
Loss on write-off of fixed assets	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	Annual
Loss on write-off of fixed assets	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	Annual
Loss on write-off of fixed assets	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	Annual
Loss on write-off of fixed assets	`GainLossOnDispositionOfAssets`	$-397.00K	USD	Annual
Prepaid expenses, other assets and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.13M	USD	Annual
Prepaid expenses, other assets and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$6.69M	USD	Annual
Prepaid expenses, other assets and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-2.77M	USD	Annual
Operating lease liabilities, net of tenant improvement allowance received	`IncreaseDecreaseInOperatingLeaseLiability`	$-5.88M	USD	Annual
Operating lease liabilities, net of tenant improvement allowance received	`IncreaseDecreaseInOperatingLeaseLiability`	$-11.47M	USD	Annual
Operating lease liabilities, net of tenant improvement allowance received	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.94M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.96M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.88M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.98M	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-4.70M	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$24.11M	USD	Annual
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$20.68M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-227.94M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-205.13M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-292.76M	USD	Annual
Maturities of investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$762.91M	USD	Annual
Maturities of investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$522.70M	USD	Annual
Maturities of investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$676.60M	USD	Annual
Purchase of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$947.66M	USD	Annual
Purchase of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$245.82M	USD	Annual
Purchase of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$725.21M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.43M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$46.79M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$37.57M	USD	Annual
Net cash provided by / (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$132.00K	USD	Annual
Net cash provided by / (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$256.45M	USD	Annual
Net cash provided by / (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-317.85M	USD	Annual
Tax payments related to shares withheld for vested restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$284.00K	USD	Annual
Tax payments related to shares withheld for vested restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$2.65M	USD	Annual
Proceeds from the issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$1.59M	USD	Annual
Proceeds from the issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$1.66M	USD	Annual
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$33.53M	USD	Annual
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$9.66M	USD	Annual
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$1.64M	USD	Annual
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$189.50M	USD	Annual
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$567.04M	USD	Annual
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$203.16M	USD	Annual
Proceeds from the issuance of debt	`ProceedsFromIssuanceOfLongTermDebt`	$1.00M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$576.42M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$239.27M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$190.15M	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$153.85M	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$11.46M	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$53.44M	USD	Annual
Cash, Cash Equivalents and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$238.16M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.31M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.85M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.42M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$238.16M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.31M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.85M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.42M	USD	Point-in-time
Net unrealized loss on investments	`UnrealizedGainLossOnInvestments`	$-620.00K	USD	Annual
Net unrealized loss on investments	`UnrealizedGainLossOnInvestments`	$-201.00K	USD	Annual
Net unrealized loss on investments	`UnrealizedGainLossOnInvestments`	$-301.00K	USD	Annual
Acquisition of property and equipment included in accounts payable and accrued expenses	`AcquisitionsOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpense`	$12.41M	USD	Annual
Acquisition of property and equipment included in accounts payable and accrued expenses	`AcquisitionsOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpense`	$5.09M	USD	Annual
Acquisition of property and equipment included in accounts payable and accrued expenses	`AcquisitionsOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpense`	$5.99M	USD	Annual
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$1.00K	USD	Annual
Lease liabilities arising from obtaining right-of-use asset from new leases	`Rightofuseassetobtainedinexchangeforoperatingleaseliabilityfromnewleases`	$553.00K	USD	Annual
Lease liabilities arising from obtaining right-of-use asset from new leases	`Rightofuseassetobtainedinexchangeforoperatingleaseliabilityfromnewleases`	$45.97M	USD	Annual
Lease liabilities arising from obtaining right-of-use asset from new leases	`Rightofuseassetobtainedinexchangeforoperatingleaseliabilityfromnewleases`	$17.27M	USD	Annual
Lease liabilities arising from obtaining right-of-use asset from lease modifications	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityFromLeaseModifications`	$826.00K	USD	Annual
Lease liabilities arising from obtaining right-of-use asset from lease modifications	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityFromLeaseModifications`	$15.30M	USD	Annual
Lease liabilities arising from obtaining right-of-use asset from lease modifications	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityFromLeaseModifications`	$7.80M	USD	Annual

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$298.97M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$499.64M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$621.66M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$656.50M	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$69.77M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$84.02M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$40.77M	USD	Annual
Common stock issued upon purchase through employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.66M	USD	Annual
Common stock issued upon purchase through employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$1.59M	USD	Annual
Vesting of restricted shares issued for services	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$112.00K	USD	Annual
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationsNet`	$-284.00K	USD	Annual
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationsNet`	$-2.65M	USD	Annual
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$33.53M	USD	Annual
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$9.66M	USD	Annual
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.64M	USD	Annual
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$189.50M	USD	Annual
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$203.16M	USD	Annual
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$567.04M	USD	Annual
Unrealized loss on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-201.00K	USD	Annual
Unrealized loss on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-301.00K	USD	Annual
Unrealized loss on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-620.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-259.58M	USD	Annual
Net loss	`NetIncomeLoss`	$-342.25M	USD	Annual
Net loss	`NetIncomeLoss`	$-395.89M	USD	Annual
Ending Balance	`StockholdersEquity`	$298.97M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$499.64M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$621.66M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$656.50M	USD	Point-in-time

Comprehensive Income 9 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-259.58M	USD	Annual
Net Loss	`NetIncomeLoss`	$-342.25M	USD	Annual
Net Loss	`NetIncomeLoss`	$-395.89M	USD	Annual
Unrealized loss on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-201.00K	USD	Annual
Unrealized loss on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-301.00K	USD	Annual
Unrealized loss on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-620.00K	USD	Annual
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-396.19M	USD	Annual
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-259.78M	USD	Annual
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-342.87M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.